The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Mendeley readers
| Title |
ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer
|
|---|---|
| Published in |
Frontiers in oncology, October 2022
|
| DOI | 10.3389/fonc.2022.955719 |
| Pubmed ID | |
| Authors |
Yilun Li, Xiaomei Liao, Li Ma |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Librarian | 1 | 20% |
| Researcher | 1 | 20% |
| Student > Doctoral Student | 1 | 20% |
| Unknown | 2 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 1 | 20% |
| Social Sciences | 1 | 20% |
| Unknown | 3 | 60% |